Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2024

  1. Antimicrobial Agent Use for Urinary Tract Infection in Long-Term Care Facilities in Spain: Results from a Retrospective Analytical Cohort Analysis

    Antibiotics, Vol. 13, Núm. 2

  2. Cross-cultural adaptation, reliability and validity of the Spanish version of the long-term quality of life questionnaire

    Frontiers in Oncology, Vol. 14

  3. Dilated cardiomyopathy associated with cardiotoxicity due to consumption of energy drinks

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 699-700

  4. The Association of Desert Dust with the Risk of Acute Coronary Syndrome in Subjects of a Younger Age

    Journal of Clinical Medicine, Vol. 13, Núm. 8

2023

  1. Effects of MIdazolam versus MOrphine in acute cardiogenic pulmonary edema and chronic obstructive pulmonary disease: An analysis of MIMO trial

    American Journal of Emergency Medicine, Vol. 73, pp. 176-181

  2. Effects of midazolam vs morphine in patients with acute pulmonary edema with left ventricular systolic dysfunction: a secondary analysis of data from the MIMO trial

    Emergencias, Vol. 35, Núm. 1, pp. 25-30

  3. Midazolam versus morphine in acute cardiogenic pulmonary edema patients with and without atrial fibrillation: findings from the MIMO trial

    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, Vol. 30, Núm. 2, pp. 78-84

2022

  1. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  2. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

  3. Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1953-1962

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling

    International Journal of Infectious Diseases, Vol. 103, pp. 19-22

  3. Socio-Demographic Health Determinants Are Associated with Poor Prognosis in Spanish Patients Hospitalized with COVID-19

    Journal of General Internal Medicine, Vol. 36, Núm. 12, pp. 3737-3742

2020

  1. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples

    International Journal of Infectious Diseases, Vol. 97, pp. 66-68

  2. Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection

    International Journal of Infectious Diseases, Vol. 99, pp. 190-192

2019

  1. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1353-1365

  2. Editor’s Choice– Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 7, pp. 667-680

  3. Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

    Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2011

  1. Users perception of risk and benefits of mood modifying drugs

    Current Clinical Pharmacology, Vol. 6, Núm. 2, pp. 108-114